Ocular manifestations of rheumatic diseases

Current Opinion in Ophthalmology

Volumn 9, Issue 6, 1998, Pages 85-88

  Baldassano Jr , Vincent F ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHCET DISEASE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENTERITIS; EYE DISEASE; GIANT CELL ARTERITIS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC DISEASE; UVEITIS; VISUAL IMPAIRMENT;

EID: 15144356730     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199812000-00015     Document Type: Review

References (23)

1. Lyons JL, Rosenbaum JT: Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Opthalmol 1997, 115:61-64.
2. Macaluso DC, Paiva E, Edwards A, Rosenbaum JT: Uveitis associated with psoriatic athritis often differs from uveitis associated with spondyloarthropathy [abstract]. ARVO 1998, 39:S609.
3. Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, Jabs DA: Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 1996, 121:47-56.
4. Boschdriessen EH, Lardy NM, Rothova A: Antinuclear antibody and HLA-B27 positive uveitis: combination of two diseases? Br J Ophthalmol 1997, 81:771-773.
5. Leirisalo-Repo M, Helenius P, Hannu T, Lehtinen A, Kreula J, Taavitsainen M, Koskimies S: Long term prognosis of reactive salmonella arthritis. Ann Rheum Dis 1997, 56:516-520.
6. Needham AD: Bilateral multifocal choroiditis in Reiter syndrome. Arch Ophthalmol 1997, 115:684-685.
7. Font C, Cid MC, Coll-Vincent B, Lopez-Soto A, Grau JM: Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997, 36:251-254.
8. Cid MC, Font C, Oristrell J, De La Seirra A, Coll-Vinent B, Lopez-Soto A, Vilaseca J, Urbano-Marquez A, Grau JM: Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998, 41:26-32.
9. Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol 1997, 42:99-123.
10. Melberg NS, Grand MG, Dieckert P, Barney NP, Blumenkranz MS, Boone DE, Folk JC, Stransky TJ: Cotton-wool spots and the early diagnosis of giant cell arteritis. Ophthalmology 1995, 102:1611-1614.
11. Finlay R: Diagnosing and managing polymyalgia rheumatica and temporal arteritis: oral prednisone 40mg daily is not adequate for temporal arteritis once vision is affected. BMJ 1997, 315:549.
12. Cornblath WT, Eggenberger ER: Progressive visual loss from giant cell arteritis depite high-dose intravenous methylprednisolone. Ophthalmology 1997, 104:854-858.
13. Akduman L, Kaplan HJ, Tychsen L: Prevalence of uveitis in an outpatient juvenile arthritis clinic: onset of uveitis more than a decade after onset of arthritis. J Pediatr Ophthalmol Strabismus 1997, 34:101-106.
14. Chalom EC, Goldsmith DP, Koehler MA, Bittar B, Rose CD, Ostrov BE, Keenan GF: Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol 1997, 24:2031-2034.
15. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS: Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Opthalmology 1997, 104:236-244.
16. Huang JL, Hung IJ, Hsieh KH: Sulphasalazine therapy in chronic uveitis of children with chronic arthritis. Asian Pacific J Allergy Immunol 1997, 15:71-75.
17. Valimaki J, Airaksinen PJ, Tuulonen A: Molteno implantation for secondary glaucoma in juvenile rheumatoid arthritis. Arch Ophthalmol 1997, 115:1253-1256.
18. Kilmartin DJ, Finch A, Acheson RW: Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol 1997, 81:649-653.
19. Dominguez LN, Irvine AR: Fundus changes in Behçet's disease. Trans Am Ophthalmol Soc 1997, 95:367-382.
20. Demiroglu H, Barista I, Dundar S: Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997, 104:701-705.
21. Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tuzun Y, Senocak M, Yazici H: Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997, 40:769-774. Early treatment with azathioprine appears to favorably affect the long-term visual prognosis of Behçet's disease.
22. Reed JB, Morse LS, Schwab IR: High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet's retinitis. Am J Ophthalmol 1998, 125:409-411.
23. Garcher C, Bielefeld P, Desvaux C, Besancenot JF, Bron A: Bilateral loss of vision and macular ischemia related to Behçet's disease. Am J Ophthalmol 1997, 124:116-117.